Table 2 Comparisons of patient clinical and pathological characteristics according to MVI
From: MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma
Variable/Parameter | MVI-positive (n = 34) | MVI-negative (n = 74) | P value |
|---|---|---|---|
Mean age (years)a | 61.56 ± 9.97 | 60.52 ± 11.53 | 0.6536 |
Age range (years) | 40–83 | 35–86 |  |
Sex ratio (M:F) | 3.25:1 | 2.36:1 | Â |
HBV, n (%) | Â | Â | 0.739 |
 Active or convalescent stage | 20 (58.82) | 41 (55.41) |  |
 Negative | 14 (41.17) | 33 (44.59) |  |
Tumor markers, n (%) | |||
 AFP ≥ 20 ng/ml | 4 (11.76) | 8 (10.81) | 1.000 |
 AFP < 20 ng/ml | 30 (88.24) | 66 (89.19) |  |
 CEA ≥ 5 ng/ml | 11 (32.35) | 16 (21.62) | 0.232 |
 CEA < 5 ng/ml | 23 (67.65) | 58 (78.38) |  |
 CA19–9 ≥ 37 U/ml | 21 (61.76) | 27 (36.49) | 0.014 |
 CA19–9 < 37 U/ml | 13 (38.24) | 47 (63.51) |  |
Pathology findings of background liver and tumor, n (%) | |||
 Edmondson-Steiner grade |  |  | 0.886 |
  G0 | 15 (44.12) | 34 (45.95) |  |
  G1-G2 | 17 (50.00) | 37 (50.00) |  |
  G3-G4 | 2 (5.88) | 3 (4.05) |  |
 Fibrosis stage |  |  | 0.472 |
  S0 | 14 (41.18) | 36 (48.65) |  |
  S1-S2 | 10 (29.41) | 24 (32.43) |  |
  S3-S4 | 10 (29.41) | 14 (18.92) |  |
  Liver cirrhosis (S4) | 5 (14.71) | 9 (12.16) | 0.715 |
  Noncirrhotic (S0-S3) | 29 (85.29) | 65 (87.84) |  |
  Fatty liver, n (%) | 5 (14.71) | 12 (16.22) | 0.819 |
  No fatty liver, n (%) | 29 (85.29) | 61 (82.43) |  |
  Tumor grade G2 | 4 (11.76) | 29 (39.19) | 0.004 |
  Tumor grade G3 | 30 (88.24) | 45 (60.81) |  |